1.
Jović S, Kozomara R, Stošić S, Jovandić S, Zeljić K, Šupić G. Pathogenic TP53 mutations influence chemotherapy response and survival rate of patients with HPV-negative oral carcinomas. Vojnosanit Pregl [Internet]. 2022 Dec. 22 [cited 2026 Jul. 12];79(11). Available from: https://asistent.ceon.rs/index.php/vsp/article/view/32402